21 CFR § 516.14 New Animal Drugs for Minor Use and Minor Species

§ 516.14 Submission of requests for designation.

Current through Sep 8, 2026 · Read all of Part 516

All correspondence relating to a request for designation of a MUMS drug must be addressed to the Director of the Office of Minor Use and Minor Species Animal Drug Development. Submissions not including all elements specified in § 516.20 will be returned to the sponsor without review.

← § 516.13 Definitions.§ 516.16 Eligibility to request designation. →